Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

If you’ve ever felt that sudden, overwhelming wave of heat—the telltale sign of a hot flash—you know how disruptive and ...

Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the use case for the menopause treatment ... known as hot flashes, caused ...

Primary and review articles published in English were identified by a MEDLINE (1966-June 2003) search using the MeSH terms "hot flashes," "hot flushes," "menopause," and "serotonin reuptake inhibitor.

New research published in Menopause, the journal of The Menopause Society, found a possible link between severe menopause ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

As I was taking a psyco-social medical history of a 43-year-old woman, I asked, “What is your problem?” She replied, “I can’t sleep at night, I can’t seem to remember anything, my muscles hurt, ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.